dibutyl phthalate has been researched along with ciproxifan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Czechtizky, W; Francon, D; Gao, Z; George, PG; Griebel, G; Hendrix, JA; Hurst, WJ; Nagorny, R; Pichat, P; Schwink, L; Stengelin, S | 1 |
1 other study(ies) available for dibutyl phthalate and ciproxifan
Article | Year |
---|---|
Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders.
Topics: Administration, Oral; Animals; Dogs; Drug Stability; Guinea Pigs; Haplorhini; Histamine H3 Antagonists; Humans; Male; Mice; Pyrans; Pyrrolidines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Histamine H3; Sheep; Sleep Disorders, Circadian Rhythm; Substrate Specificity | 2013 |